Data / Form D filings / LYCERA CORP
LYCERA CORP: Form D filings
LYCERA CORP, a pharmaceuticals company in Ann Arbor, MI, filed 5 Form D notices with the SEC between 2009 and 2015. The latest, on June 22, 2015, reports $29.9 million sold of an offering with no set size to 22 investors.
Find out what LYCERA CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2800 PLYMOUTH ROAD, NCRC, BUILDING 26, Ann Arbor, MI, 48109
- Phone
- (734) 764-4548
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1382268
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2015 | New notice | Indefinite | $29,892,748 | Indefinite | 22 | Jun 12, 2015 | sec.gov |
| Apr 4, 2014 | New notice | $9,183,393 | $4,000,000 | $5,183,393 | 6 | Mar 21, 2014 | sec.gov |
| Oct 21, 2013 | New notice | $5,739,621 | $5,000,000 | $739,621 | 5 | Oct 11, 2013 | sec.gov |
| Jun 28, 2012 | Amendment | $38,917,556 | $33,917,556 | $5,000,000 | 17 | Apr 7, 2009 | sec.gov |
| Apr 15, 2009 | New notice | $38,917,556 | $12,917,557 | $25,999,999 | 17 | Apr 7, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Kamen | Director | |
| Michael Hayden | Director | |
| Michael Steinmetz | Director | |
| Steven Gillis | Director | |
| Paul Sekhri | Executive Officer | |
| Kristina Burow | Director | |
| Timothy Mayleben | Director | |
| Nina Kjellson | Director |
Other pharmaceuticals companies in Michigan that filed recently
- IMACS Working Capital Facility One LLC $200,000 · Sep 17, 2026
Every Form D from the week of Jun 22, 2015 · All recent filings in Michigan · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LYCERA CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.